Viewing Study NCT06603090



Ignite Creation Date: 2024-10-25 @ 7:56 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06603090
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-17

Brief Title: Text4Vax Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
Sponsor: None
Organization: None

Study Overview

Official Title: Text4Vax Understanding the Effectiveness and Implementation of Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-2025 Season
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics AAP Pediatric Research in Office Settings PROS network
Detailed Description: The study is to be conducted over the 1st season September 2024-April 2025 as an effectiveness trial and the 2nd September 2025-April 2026 as a replication study This protocol covers the first season Parents of eligible children who are 6 month-17 year-old who are due for both a COVID-19 and influenza vaccine will be sent text messages Within each practice site parents of eligible children will be randomized to receive either 1 combined COVID-19 and influenza vaccine text message reminders 2 COVID-19 reminders alone 3 influenza reminders alone or 4 no reminders usual care

Randomization is to be stratified by practice site age group and prior years COVID-19influenza vaccine history Messages will be sent centrally and managed by the research team

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None